Cocrystal Pharma, Inc. (COCP) financial statements (2022 and earlier)

Company profile

Business Address 19805 N. CREEK PARKWAY
BOTHELL, WA 98011
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments58,70533,0107,4182,7237483,6409,276
Cash and cash equivalents58,70533,0107,4182,7237483,6409,276
Restricted cash and investments50505029   
Receivables 556644 121(2,400)
Other undisclosed current assets5683991691911,4271,8113,043
Total current assets:59,32334,0158,2812,9432,1765,4729,919
Noncurrent Assets
Operating lease, right-of-use asset478498677
Property, plant and equipment453591431384119280430
Intangible assets, net (including goodwill)19,09219,09219,09265,19565,19565,19565,195
Goodwill19,09219,09219,09265,19565,19565,19565,195
Deposits noncurrent assets464650    
Deferred costs    9611,3231,098
Other undisclosed noncurrent assets   4052,97552,613147,588
Total noncurrent assets:20,06920,22720,25065,619119,250119,411214,311
TOTAL ASSETS:79,39254,24228,53168,562121,426124,883224,230
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1,2971,0801,9991,0778375632,535
Accounts payable5786571,511616   
Accrued liabilities615297405383 5632,535
Employee-related liabilities1041268378   
Other undisclosed accounts payable and accrued liabilities    837  
Debt2739280214   
Deferred rent credit   3
Derivative instruments and hedges, liabilities126172635691,476 
Other undisclosed current liabilities209178    4,165
Total current liabilities:1,5451,3582,2861,5571,4062,0396,700
Noncurrent Liabilities
Long-term debt and lease obligation2983795371171,007  
Long-term debt, excluding current maturities    1,007  
Finance lease, liability73414
Capital lease obligations117   
Operating lease, liability291345523
Liabilities, other than long-term debt    13,61320,46249,875
Deferred revenue and credits31  
Deferred tax liabilities, net 13,58220,46249,875
Other undisclosed noncurrent liabilities(291)(345)   6361
Total noncurrent liabilities:29837953711714,62020,52549,936
Total liabilities:1,8431,7372,8231,67416,02622,56456,636
Stockholders' equity
Stockholders' equity attributable to parent77,54952,50525,70866,888105,400102,319167,594
Common stock9871363024714694
Additional paid in capital336,544297,342260,932253,949243,419239,035229,456
Accumulated deficit(259,093)(244,908)(235,260)(187,091)(138,043)(137,430)(62,556)
Total stockholders' equity:77,54952,50525,70866,888105,400102,319167,594
TOTAL LIABILITIES AND EQUITY:79,39254,24228,53168,562121,426124,883224,230

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues 2,0146,564  12678
Revenue, net  78
Net investment income    (7)126 
Gross profit: 2,0146,564  12678
Operating expenses(14,221)(11,600)(54,970)(62,924)(8,262)(105,819)(54,026)
Other undisclosed operating income (loss)    7(126) 
Operating loss:(14,221)(9,586)(48,406)(62,924)(8,262)(105,819)(53,948)
Nonoperating income (expense)36(62)2372947691,551(11,422)
Foreign currency transaction loss, before tax(9)      
Other nonoperating income (expense)     1,551(11,422)
Interest and debt expense(4)(8) (58)   
Other undisclosed income from continuing operations before equity method investments, income taxes 8 58   
Loss from continuing operations before income taxes:(14,189)(9,648)(48,169)(62,630)(7,493)(104,268)(65,370)
Income tax benefit   13,5826,88029,39415,248
Net loss:(14,189)(9,648)(48,169)(49,048)(613)(74,874)(50,122)
Other undisclosed net income attributable to parent4      
Net loss available to common stockholders, diluted:(14,185)(9,648)(48,169)(49,048)(613)(74,874)(50,122)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(14,189)(9,648)(48,169)(49,048)(613)(74,874)(50,122)
Comprehensive loss, net of tax, attributable to parent:(14,189)(9,648)(48,169)(49,048)(613)(74,874)(50,122)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: